Morgan Stanley Upgrades Keryx Biopharmaceuticals (KERX) to Equalweight
Tweet Send to a Friend
Morgan Stanley upgraded Keryx Biopharmaceuticals (NASDAQ: KERX) from Underweight to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
